Thursday, January 20, 2011

Behavioral therapy reduces postprostatectomy incontinence

According to a study published in JAMA, 65% of men experience urinary incontinence up to 5 years following radical prostatectomy.

American researchers conducted a randomized controlled trial involving 208 men aged 51 - 84 with incontinence persisting 1 to 17 years after radical prostatectomy, to evaluate the effectiveness of behavioral therapy for reducing post-prostatectomy incontinence and to determine whether biofeedback and electrical stimulation enhance its effectiveness. 24% of the men were black and 75 % white.

The researchers found that over the 8-week treatment period, those in the behavioral therapy group had an average reduction of incontinence episodes of 55 % (from 28 to 13 episodes per week), while the control group had an average reduction of only 24 % ( from 25 to 21 episodes per week). Those in the behavior-plus group experienced an average reduction of 51% (from 26 to 12 episodes per week), indicating that the addition of biofeedback and electrical stimulation did not improve the 8-week results compared with behavioral therapy alone.

Improvements were evident up to a year in the treatment groups, 50% reduction in the behavioral group and 59% in the behavior plus group. By the end of the treatment period, 15.7 % of men in the behavior therapy group, 17.1% in the behavior-plus group, and 5.9% in the control group achieved complete continence.

The researchers concluded that for men with incontinence following radical prostatectomy, behavioral therapy resulted in significant reduction in incontinence espisodes and that these findings have important implications for doctors and patients.

In an accompanying editorial, the author wrote that the optimal way to address postprostatectomy incontinence remains unanswered and that a better strategy would be primary prevention.

Source: Behavioral Therapy With or Without Biofeedback and Pelvic Floor Electrical Stimulation for Persistent Postprostatectomy Incontinence - A Randomized Controlled Trial. JAMA. 2011;305(2):151-159. (f/t via Athens)




No comments: